GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE)

CUSIP: 37185R208

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / SPON ADR 150SHS
Total 13F shares
594,442
Share change
-89,664
Total reported value
$351,047
Price per share
$0.59
Number of holders
10
Value change
-$109,931
Number of buys
6
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 37185R208?
CUSIP 37185R208 identifies GENE - GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) as of Q2 2019

As of 30 Jun 2019, GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 594,442 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, Alpine Group USVI, LLC, Virtu Financial LLC, UBS Group AG, OLD MISSION CAPITAL LLC, Cambridge Investment Research Advisors, Inc., JANE STREET GROUP, LLC, Cutler Group LP, and BREWIN DOLPHIN LTD. This page lists 10 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.